Impax Laboratories
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Impax Laboratories generated cash of $0, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore $529,000.
Cash Flow
| 2013 | 149.94M | -115.89M | 8.96M |
|---|---|---|---|
| 2014 | 32.81M | -16.60M | 14.41M |
| 2015 | 71.92M | -467.53M | 521.38M |
| 2016 | 74.59M | -627.09M | 391.78M |
| 2017 | 0 | 529K | 0 |
IPXL Cash Flow Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Cash at beginning of period | 0 | 340.35M | 214.87M | 184.61M | 142.16M |
Operating activities | |||||
Net income | 0 | -472.03M | 38.99M | 57.35M | 101.25M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 88.34M | 68.63M | 34.02M | 36.00M |
Stock-based compensation expense | 0 | 32.18M | 28.61M | 20.88M | 17.64M |
| Deferred income tax benefit | 0 | 32.18M | 28.61M | 20.88M | 17.64M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 26.77M | -121.11M | -33.49M | -20.74M |
Inventories | 0 | -45.56M | -5.85M | -24.30M | 7.09M |
Accounts payable | 0 | 13.71M | 57.43M | -18.93M | -2.94M |
Cash generated by operating activities | 0 | 74.59M | 71.92M | 32.81M | 149.94M |
Investing activities | |||||
Purchases Of Investments | 0 | -4.75M | -4.75M | -369.09M | -357.09M |
Investments In Property Plant And Equipment | 0 | -52.90M | -31.04M | -42.91M | -44.78M |
Acquisitions Net | 0 | -585.8M | -691.34M | 13M | 12M |
Cash generated by investing activities | 529K | -627.09M | -467.53M | -16.60M | -115.89M |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -5M | 600M | 0 | 0 |
Cash used in financing activities | 0 | 391.78M | 521.38M | 14.41M | 8.96M |
Net Change In Cash | 529K | -160.21M | 125.47M | 30.26M | 42.45M |
Cash at end of period | 529K | 180.13M | 340.35M | 214.87M | 184.61M |